SUBSCRIBERS

As biotech selling spreads, more weakness is seen for US health stocks

Published Sun, Oct 25, 2015 · 09:50 PM

New York

AFTER a four-year love affair with healthcare shares, investors are moving on.

Selling has spread from biotechs - shaken on Sept 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares of everything from hospitals to traditional pharmaceutical companies and insurers in recent weeks.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes

Consumer & Healthcare

Billionaire Geiger is said to near US$7 billion L’Occitane buyout
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years

Companies & Markets

As biotech selling spreads, more weakness is seen for US health stocks

Consumer & Healthcare

Billionaire Geiger is said to near US$7 billion L’Occitane buyout

HCA beats first-quarter profit estimates on higher patient admissions

US FDA approves Pfizer’s gene therapy for rare bleeding disorder

EU toughens rules on Chinese fashion retailer Shein

Best World under fire from shareholders at AGM over dividends, director salaries

‘Extreme’ climate blamed for world’s worst wine harvest in 62 years

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

SECTIONS

LIFESTYLE

Follow BT